Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alemtuzumab in Advanced Mycosis Fungoides/Sezary Syndrome
NCT00157274Phase 2Unknown
- Sponsor
- Latin American Cooperative Onco-Haematology Group - Peru
- Start
- Jul 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of alemtuzumab in mycosis fungoides (MF), Sézary syndrome (SS), sponsored by Latin American Cooperative Onco-Haematology Group - Peru. Status: unknown.
02
Drugs
alemtuzumab
03
Conditions
mycosis fungoides (MF)Sézary syndrome (SS)
Beyond the preview
Go deeper on NCT00157274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157274.